© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > S64315
<< Back to November
potent and selective Mcl-1 PPI inhibitor
completed Ph. I in AML/MDS (IV weekly)
from NMR fragment screening and SBDD
J. Med. Chem., Nov. 4, 2020
Servier, HU + FR / Vernalis, UK
Servier selective clinical Mcl-1 protein-protein interaction (PPI) inhibitor
Unlock this content with a Premium membership to read it now.